tradingkey.logo
tradingkey.logo
검색

Pediatrix Medical Group Inc

MD
관심 목록에 추가
26.140USD
+0.810+3.20%
종가 07/01, 16:00ET시세는 15분 지연됩니다
2.15B시가총액
12.52P/E TTM

Pediatrix Medical Group Inc

26.140
+0.810+3.20%

자세한 내용은 Pediatrix Medical Group Inc 회사

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by pediatric subspecialties. It offers specialized and critical care services through approximately 4,400 affiliated physicians and other clinicians. It provides neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. The Company provides maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Pediatrix Medical Group Inc 정보

종목 코드 MD
회사 이름Pediatrix Medical Group Inc
상장일Sep 20, 1995
CEOOrdan (Mark S)
직원 수2150
유형Ordinary Share
회계 연도 종료Sep 20
주소1301 Concord Terrace
도시SUNRISE
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호33323
전화19543840175
웹사이트https://www.pediatrix.com/
종목 코드 MD
상장일Sep 20, 1995
CEOOrdan (Mark S)

Pediatrix Medical Group Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Mark S. Ordan
Mr. Mark S. Ordan
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
605.23K
+17.86%
Ms. Mary Ann E. Moore
Ms. Mary Ann E. Moore
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
234.39K
-12.95%
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Lead Independent Director
Lead Independent Director
86.94K
+8.28%
Mr. Michael A. Rucker
Mr. Michael A. Rucker
Independent Director
Independent Director
66.30K
+10.85%
Ms. Shirley A. Weis
Ms. Shirley A. Weis
Independent Director
Independent Director
54.65K
+13.17%
Mrs. Sylvia Jean Young
Mrs. Sylvia Jean Young
Independent Director
Independent Director
47.81K
+15.05%
Ms. Laura A. Linynsky
Ms. Laura A. Linynsky
Independent Director
Independent Director
39.43K
+18.25%
Mr. Thomas A. Mceachin
Mr. Thomas A. Mceachin
Independent Director
Independent Director
--
--
Mr. John M. Starcher, Jr., Esq.
Mr. John M. Starcher, Jr., Esq.
Independent Director
Independent Director
--
--
Dr. James D. (Jim) Swift, M.D.
Dr. James D. (Jim) Swift, M.D.
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Mark S. Ordan
Mr. Mark S. Ordan
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
605.23K
+17.86%
Ms. Mary Ann E. Moore
Ms. Mary Ann E. Moore
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
234.39K
-12.95%
Mr. Guy P. Sansone
Mr. Guy P. Sansone
Lead Independent Director
Lead Independent Director
86.94K
+8.28%
Mr. Michael A. Rucker
Mr. Michael A. Rucker
Independent Director
Independent Director
66.30K
+10.85%
Ms. Shirley A. Weis
Ms. Shirley A. Weis
Independent Director
Independent Director
54.65K
+13.17%
Mrs. Sylvia Jean Young
Mrs. Sylvia Jean Young
Independent Director
Independent Director
47.81K
+15.05%

자주 묻는 질문

Pediatrix Medical Group Inc의 상위 5대 주주는 누구인가요?

Pediatrix Medical Group Inc의 상위 5대 주주는 다음과 같습니다: Mr. Mark S. Ordan

Pediatrix Medical Group Inc(MD)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Pediatrix Medical Group Inc의 주식을 보유한 기관은 총 588곳이며, 이들이 보유한 주식의 총 가치는 약 98.68M로 전체 발행 주식의 120.16%를 차지합니다. 이는 2025Q4 대비 287699.00 증가한 수치입니다.

Pediatrix Medical Group Inc의 최대 수익원은 무엇인가요?

2026Q1 기준, Pediatrix Medical Group Inc의 Neonatology and other pediatric subspecialties 부문이 가장 높은 매출을 기록했으며, 금액은 1.67B로 전체 매출의 83.00%를 차지했습니다.